These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17021272)

  • 1. A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss.
    Santini D; Vincenzi B; Caraglia M; Tonini G
    Ann Oncol; 2007 Jan; 18(1):201-202. PubMed ID: 17021272
    [No Abstract]   [Full Text] [Related]  

  • 2. Symptomatic hypocalcemia following intravenous administration of zoledronic acid in a breast cancer patient.
    Mishra A
    J Postgrad Med; 2008; 54(3):237. PubMed ID: 18626181
    [No Abstract]   [Full Text] [Related]  

  • 3. Unilateral anterior uveitis complicating zoledronic acid therapy in prostate cancer.
    Banal F; Briot K; Ayoub G; Dougados M; Roux C
    J Rheumatol; 2008 Dec; 35(12):2458-9. PubMed ID: 19040323
    [No Abstract]   [Full Text] [Related]  

  • 4. Multicenter Study on Observation of Acute-phase Responses After Infusion of Zoledronic Acid 5 mg in Chinese Women with Postmenopausal Osteoporosis.
    Ding Y; Zeng JC; Yin F; Zhang CL; Zhang Y; Li SX; Liu X; Zhang C; Xue QY; Lin H; Pei FX
    Orthop Surg; 2017 Aug; 9(3):284-289. PubMed ID: 28960821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-up.
    Majithia N; Atherton PJ; Lafky JM; Wagner-Johnston N; Olson J; Dakhil SR; Perez EA; Loprinzi CL; Hines SL
    Support Care Cancer; 2016 Mar; 24(3):1219-26. PubMed ID: 26298334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of acquired Fanconi syndrome induced by zoledronic acid.
    Yoshinami T; Yagi T; Sakai D; Sugimoto N; Imamura F
    Intern Med; 2011; 50(9):1075-9. PubMed ID: 21532237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute unilateral anterior uveitis and scleritis following a single infusion of zoledronate for metastatic breast cancer.
    Moore MM; Beith JM
    Med J Aust; 2008 Mar; 188(6):370-1. PubMed ID: 18341464
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute anterior uveitis associated with the use zoledronic acid].
    Cavallasca JA; Reyt C
    Medicina (B Aires); 2014; 74(5):428-9. PubMed ID: 25347912
    [No Abstract]   [Full Text] [Related]  

  • 9. Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.
    Gnant MF; Mlineritsch B; Luschin-Ebengreuth G; Grampp S; Kaessmann H; Schmid M; Menzel C; Piswanger-Soelkner JC; Galid A; Mittlboeck M; Hausmaninger H; Jakesz R;
    J Clin Oncol; 2007 Mar; 25(7):820-8. PubMed ID: 17159195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Undetectable Urine Calcium in a Gastric Bypass Patient.
    Campbell ST; Santen RJ; Bruns DE
    Clin Chem; 2016 Aug; 62(8):1161. PubMed ID: 27471247
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacist-run zoledronic acid clinic.
    Traina AN; Kane MP; Bakst G; Abelseth JM; Busch RS
    Am J Health Syst Pharm; 2011 Aug; 68(15):1399-403. PubMed ID: 21785027
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical oncology: Zoledronic acid for breast cancer therapy-induced bone loss.
    Amir E; Ocaña A; Seruga B; Josse R; Clemons M
    Nat Rev Clin Oncol; 2010 Apr; 7(4):187-8. PubMed ID: 20354540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneously recovered severe thrombocytopaenia following zoledronic acid infusion for osteoporosis.
    Kulkarni P; Cushman T; Donthireddy V; Rao S
    BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26843222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant cell arteritis with visual loss following zoledronic acid infusion.
    Metyas S; Ibrahim M; Solyman J; Yeter KC; Arkfeld DG
    Int J Rheum Dis; 2014 Jan; 17(1):113-5. PubMed ID: 24472274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
    Gnant M; Mlineritsch B; Schippinger W; Luschin-Ebengreuth G; Pöstlberger S; Menzel C; Jakesz R; Seifert M; Hubalek M; Bjelic-Radisic V; Samonigg H; Tausch C; Eidtmann H; Steger G; Kwasny W; Dubsky P; Fridrik M; Fitzal F; Stierer M; Rücklinger E; Greil R; ; Marth C
    N Engl J Med; 2009 Feb; 360(7):679-91. PubMed ID: 19213681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteonecrosis of the jaw (ONJ) risk in breast cancer patients after zoledronic acid treatment.
    Fusco V; Loidoris A; Colella G; Vescovi P; Campisi G
    Breast; 2010 Oct; 19(5):432-3; author reply 433-4. PubMed ID: 20363135
    [No Abstract]   [Full Text] [Related]  

  • 17. Zoledronic acid: a review of its use in the treatment of osteoporosis.
    Deeks ED; Perry CM
    Drugs Aging; 2008; 25(11):963-86. PubMed ID: 18947264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of zoledronic acid on osteoporosis patients in Japan.].
    Tanaka S
    Clin Calcium; 2017; 27(2):257-261. PubMed ID: 28123128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zoledronic acid induced osteonecrosis of tibia and femur.
    Gupta S; Jain P; Kumar P; Parikh PM
    Indian J Cancer; 2009; 46(3):249-50. PubMed ID: 19574685
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-induced dermatomyositis after zoledronic acid.
    Tong PL; Yu LL; Chan JJ
    Australas J Dermatol; 2012 Nov; 53(4):e73-5. PubMed ID: 23157790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.